Global Information
회사소개 | 문의 | 비교리스트

세계의 BCG 백신 시장(약제 종류, 최종 용도, 사용법, 용도별) : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년)

Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

리서치사 Koncept Analytics
발행일 2020년 06월 상품 코드 941643
페이지 정보 영문 97 Pages
가격
US $ 1,600 ₩ 1,802,000 PDF (Single User License)
US $ 2,200 ₩ 2,477,000 PDF (Corporate User License)


세계의 BCG 백신 시장(약제 종류, 최종 용도, 사용법, 용도별) : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년) Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
발행일 : 2020년 06월 페이지 정보 : 영문 97 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 BCG 백신 시장은 2020-2024년의 예측기간 중 4.7%의 CAGR로 성장하여, 2024년에는 6,553만 달러에 달할 것으로 예측됩니다. 시장의 주요 성장 촉진요인으로 결핵 유병률 증가, 결핵에 대한 R&D 자금 증가, 방광암 발생률 증가, 광범위한 약제 내성 결핵의 유병률 증가, BCG 예방 접종률 급증 등을 들 수 있습니다.

세계의 BCG 백신(BCG Vaccine) 시장에 대해 조사했으며, 시장 성장 촉진요인, 시장 동향, 과제, COVID-19의 영향, 약제 종류·최종사용자·사용·용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 시장 개요

  • BCG 백신
  • 의료용 : 결핵
  • 의료용 : 암
  • 의료용 : 마이코박테리아
  • BCG의 투여 방법
  • BCG의 악영향
  • BCG로 취하는 예방책
  • BCG의 부작용

제2장 COVID-19의 영향

  • 세계 경제에 대한 영향
  • 오가닉 트래픽의 변화
  • COVID-19의 세계 유행

제3장 시장 분석

  • 매출별 : 세계 시장
  • 매출별 : 세계 시장 예측
  • 약제 종류별
  • 최종사용자별
  • 사용별
  • 용도별
  • 지역별

제4장 지역 시장

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제5장 시장 역학

  • 성장 촉진요인
    • 결핵 급증
    • 결핵 조사개발 자금 증가
    • 방광암 발생률 상승
    • 결핵에 대한 미국의 자금 조달 급증
    • 광범위한 약제 내성 결핵의 유병률 상승
    • BCG 예방 접종의 대상 범위 확대
  • 주요 동향·진전
    • 결핵의 목표 발생률 감소
    • 결핵의 목표 사망률 감소
  • 과제
    • 성인에 대한 BCG의 영향은 한정적

제6장 경쟁 상황

  • 세계 시장
    • 매출 비교 : 주요 기업
    • 시가총액 비교 : 주요 기업
    • 조사개발비 비교 : 주요 기업
    • 세계 시장 점유율 비교 : 주요 기업

제7장 기업 개요

  • Merck & Co.
  • Sanofi(Sanofi Pasteur)
  • Statens Serum Institut
  • China National Biotec Group(China National Pharmaceutical Group)
  • Serum Institute of India Pvt. Ltd.(SII)
  • Green Signal Bio Pharma Ltd.
KSM 20.06.25

List of Charts

  • Medical Uses of BCG Vaccine
  • Medical Use of BCG: Mycobacteria
  • Medical Use of BCG: Mycobacteria
  • Side Effects of BCG
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global COVID-19 Infected Cases (Jan'20 - May'20)
  • Global BCG Vaccine Market by Value (2015-2019)
  • Global BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Drug Type (2019)
  • Global Immune BCG Market by Value (2015-2019)
  • Global Immune BCG Market Forecast by Value (2020-2024)
  • Global Therapy BCG Market by Value (2015-2019)
  • Global Therapy BCG Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by End User (2019)
  • Global Pediatric BCG Vaccine Market by Value (2015-2019)
  • Global Pediatric BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Adult BCG Vaccine Market by Value (2015-2019)
  • Global Adult BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Usage (2019)
  • Global Tuberculosis BCG Vaccine Market by Value (2015-2019)
  • Global Tuberculosis BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Bladder Cancer BCG Vaccine Market by Value (2015-2019)
  • Global Bladder Cancer BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Application (2019)
  • Global Hospital BCG Vaccine Market Forecast by Value (2019-2024)
  • Global Clinic BCG Vaccine Market Forecast by Value (2019-2024)
  • Global BCG Vaccine Market by Region (2019)
  • North America BCG Vaccine Market by Value (2015-2019)
  • North America BCG Vaccine Market Forecast by Value (2020-2024)
  • Europe BCG Vaccine Market by Value (2015-2019)
  • Europe BCG Vaccine Market Forecast by Value (2020-2024)
  • Asia Pacific BCG Vaccine Market by Value (2015-2019)
  • Asia Pacific BCG Vaccine Market Forecast by Value (2020-2024)
  • ROW BCG Vaccine Market by Value (2015-2019)
  • ROW BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Prevalence of Tuberculosis (2014-2019)
  • Global TB Research & Development Funding (2013-2019)
  • Global Incidence of Bladder Cancer (2014-2019)
  • The US Funding for Global Tuberculosis (2014-2020)
  • Global Prevalence of Extensively Drug-Resistant Tuberculosis (2014-2019)
  • Global BCG Immunization Coverage Rate (2014-2019)
  • Global Targeted Incidence Rate of Tuberculosis (2015-2035)
  • Global Targeted Mortality of Tuberculosis (2015-2035)
  • Key Players - Revenue Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
  • Key Players - R&D Expenses Comparison (2019)
  • Key Players - Global BCG Market Share Comparison (2019)
  • Merck & Co. Sales & Net Income (2015-2019)
  • Merck & Co. Sales by Segment (2019)
  • Merck & Co. Sales by Region (2019)
  • Sanofi Net Sales & Net Income (2015-2019)
  • Sanofi Net Sales by Segment (2019)
  • Sanofi Net Sales by Region (2019)

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.

The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.

The global BCG vaccine market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the market during the period spanning 2020-2024, supported by growing tobacco consumption and increasing technological advancements in BCG vaccination.

Scope of the report:

The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.

The major regional markets (North America, Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.

Key Target Audience:

  • BCG Vaccine Providers/Hospitals
  • API Suppliers
  • End Users (Businesses/Consumers)
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1. BCG Vaccine
  • 1.2. Medical Use: Tuberculosis
  • 1.3. Medical Use: Cancer
  • 1.4. Medical Use: Mycobacteria
  • 1.5. Methods of Administration of BCG
  • 1.6. Adverse Effects of BCG
  • 1.7. Precautions to be taken in BCG
  • 1.8. Side Effects of BCG

2. Impact of COVID-19

  • 2.1. Impact on Global Economy
  • 2.2. Change in Organic Traffic
  • 2.3. Global Prevalence of COVID-19

3. Market Analysis

  • 3.1. Global BCG Vaccine Market by Value
  • 3.2. Global BCG Vaccine Market Forecast by Value
  • 3.3. Global BCG Vaccine Market by Drug Type
    • 3.3.1. Global Immune BCG Market by Value
    • 3.3.2. Global Immune BCG Market Forecast by Value
    • 3.3.3. Global Therapy BCG Market by Value
    • 3.3.4. Global Therapy BCG Market Forecast by Value
  • 3.4. Global BCG Vaccine Market by End User
    • 3.4.1. Global Pediatric BCG Vaccine Market by Value
    • 3.4.2. Global Pediatric BCG Vaccine Market Forecast by Value
    • 3.4.3. Global Adult BCG Vaccine Market by Value
    • 3.4.4. Global Adult BCG Vaccine Market Forecast by Value
  • 3.5. Global BCG Vaccine Market by Usage
    • 3.5.1. Global Tuberculosis BCG Vaccine Market by Value
    • 3.5.2. Global Tuberculosis BCG Vaccine Market Forecast by Value
    • 3.5.3. Global Bladder Cancer BCG Vaccine Market by Value
    • 3.5.4. Global Bladder Cancer BCG Vaccine Market Forecast by Value
  • 3.6. Global BCG Vaccine Market by Application
    • 3.6.1. Global Hospital BCG Vaccine Market Forecast by Value
    • 3.6.2. Global Clinic BCG Vaccine Market Forecast by Value
  • 3.7. Global BCG Vaccine Market by Region

4. Regional Market

  • 4.1. North America
    • 4.1.1. North America BCG Vaccine Market by Value
    • 4.1.2. North America BCG Vaccine Market Forecast by Value
  • 4.2. Europe
    • 4.2.1. Europe BCG Vaccine Market by Value
    • 4.2.2. Europe BCG Vaccine Market Forecast by Value
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific BCG Vaccine Market by Value
    • 4.3.2. Asia Pacific BCG Vaccine Market Forecast by Value
  • 4.4. ROW
    • 4.4.1. ROW BCG Vaccine Market by Value
    • 4.4.2. ROW BCG Vaccine Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Surging Prevalence of Tuberculosis
    • 5.1.2. Increasing Research & Development Funding on Tuberculosis
    • 5.1.3. Rising Incidence of Bladder Cancer
    • 5.1.4. Upsurge in the US Funding for Tuberculosis
    • 5.1.5. Rising Prevalence of Extensively Drug-Resistant Tuberculosis
    • 5.1.6. Increasing BCG Immunization Coverage
  • 5.2. Key Trends & Developments
    • 5.2.1. Declining Targeted Incidence Rate of Tuberculosis
    • 5.2.2. Decreasing Targeted Mortality of Tuberculosis
  • 5.3. Challenges
    • 5.3.1. Limited Impact of BCG on Adults

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Revenue Comparison- Key Players
    • 6.1.2. Market Capitalization Comparison- Key Players
    • 6.1.3. Research & Development Expenses Comparison - Key Players
    • 6.1.4. Global BCG Market Share Comparison - Key Players

7. Company Profiles

  • 7.1. Merck & Co.
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Sanofi (Sanofi Pasteur)
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Statens Serum Institut
    • 7.3.1. Business Overview
    • 7.3.2. Business Strategies
  • 7.4. China National Biotec Group (China National Pharmaceutical Group)
    • 7.4.1. Business Overview
    • 7.4.2. Business Strategies
  • 7.5. Serum Institute of India Pvt. Ltd. (SII)
    • 7.5.1. Business Overview
    • 7.5.2. Business Strategies
  • 7.6. Green Signal Bio Pharma Ltd.
    • 7.6.1. Business Overview
    • 7.6.2. Business Strategies
Back to Top
전화 문의
F A Q